Technology ID
TAB-3192
Hybridoma Cell Line H1.2F3 Producing Monoclonal Anti-mouse CD69 (Early activation marker) Antibody
E-Numbers
B-004-1991-3
Lead Inventor
Shevach, Ethan (NIAID)
Applications
Research Materials
Lead IC
NIAID
ICs
NIAID
A hybridoma cell line producing a monoclonal hamster antibody specific to mouse CD69 (early activation marker) (clone H1.2F3) as described in J Immunol. 1988 Jul 15;141(2):369-76 and developed by the laboratory of Dr. Ethan Shevach at the National Institute of Allergy and Infectious Diseases.
Commercial Applications
- A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
- Speed up product development with NIH developed material that has already been tested and validated.
Licensing Contact: